Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia · Delayed Price · Currency is SAR 6.10
0.00 (0.00%)
Sep 27, 2026, 2:11 PM AST
TADAWUL:9626 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 54.93 | 45.46 | 33.92 | 26.52 | 21.92 | |
Revenue Growth | 47.28% | 34.02% | 27.88% | 20.99% | - |
Cost of Revenue | 39.07 | 32.14 | 22.9 | 18.19 | 15.02 |
Gross Profit | 15.86 | 13.31 | 11.02 | 8.33 | 6.9 |
Selling, General & Admin | 5.97 | 5.26 | 4.06 | 2.48 | 2.57 |
Operating Expenses | 5.97 | 5.26 | 4.06 | 2.74 | 2.69 |
Operating Income | 9.89 | 8.06 | 6.96 | 5.59 | 4.21 |
Interest Expense | -0.72 | -0.75 | -0.34 | -0.36 | -0.29 |
Interest & Investment Income | 1.31 | 0.84 | 0.1 | - | - |
Other Non Operating Income (Expenses) | 0.13 | 0.07 | 0.06 | -0.3 | - |
EBT Excluding Unusual Items | 10.61 | 8.21 | 6.78 | 4.93 | 3.92 |
Gain (Loss) on Sale of Assets | - | 0.04 | - | - | - |
Other Unusual Items | - | - | -0 | 0.13 | - |
Pretax Income | 10.61 | 8.25 | 6.78 | 5.06 | 3.92 |
Income Tax Expense | 1.08 | 0.94 | 0.48 | 0.19 | 0.14 |
Net Income | 9.53 | 7.3 | 6.3 | 4.87 | 3.78 |
Net Income to Common | 9.53 | 7.3 | 6.3 | 4.87 | 3.78 |
Net Income Growth | 47.24% | 15.93% | 29.40% | 28.71% | - |
Shares Outstanding (Basic) | 18 | 18 | 12 | 10 | - |
Shares Outstanding (Diluted) | 18 | 18 | 12 | 10 | - |
Shares Change | 14.36% | 56.17% | 21.59% | - | - |
EPS (Basic) | 0.52 | 0.40 | 0.55 | 0.51 | - |
EPS (Diluted) | 0.52 | 0.40 | 0.55 | 0.51 | - |
EPS Growth | 28.75% | -25.77% | 6.42% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 6.71 | 4.76 | 6.66 | 4.07 | 5.24 |
Free Cash Flow Per Share | 0.36 | 0.26 | 0.58 | 0.43 | - |
Gross Margin | 28.87% | 29.29% | 32.50% | 31.41% | 31.46% |
Operating Margin | 18.00% | 17.72% | 20.53% | 21.07% | 19.20% |
Profit Margin | 17.35% | 16.07% | 18.58% | 18.36% | 17.26% |
Free Cash Flow Margin | 12.22% | 10.47% | 19.64% | 15.34% | 23.90% |
EBITDA | 11.22 | 9.09 | 7.59 | 6.2 | 4.54 |
EBITDA Margin | 20.43% | 19.99% | 22.37% | 23.36% | 20.71% |
D&A For EBITDA | 1.33 | 1.03 | 0.62 | 0.61 | 0.33 |
EBIT | 9.89 | 8.06 | 6.96 | 5.59 | 4.21 |
EBIT Margin | 18.00% | 17.72% | 20.53% | 21.07% | 19.20% |
Effective Tax Rate | 10.15% | 11.45% | 7.11% | 3.69% | 3.56% |
Advertising Expenses | - | 0.31 | 0.15 | - | - |